Members
Margin of Safety Dashboard
Finch Trades
Research Notes
My Profile
Logout
Investing
Member Benefits
Stocks We Cover
Public
Articles
Data Visualizations
Newsletter
Newsletter
About
What Is Solt DB?
Public Benefit
Our Lonely Team
Pricing
Login
Newsletter
My Profile
Login
Finch Trades
As of market close
January 23, 2026
Transaction
Position
Overall
Group
Year
Company
Ticker
Entry Date
Group
Status
Principal
Cost Basis
Last Price
Last Value
% Change
vs. SPY
Harmony Biosciences
$HRMY
5/2/25
Current Compounder
Active
Exited
3
$23,245
$30.00
$36.82
$28,529
22.7%
1.5%
Exact Sciences
$EXAS
4/30/25
Opportunistic
Active
Exited
10
$10,000
$44.69
$53.05
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
4/30/25
Opportunistic
Active
Exited
10
$10,000
$88.21
$98.73
$11,193
11.9%
8.9%
Coherus Oncology
$CHRS
3/27/25
Future Compounder
Active
Exited
2
$250
$0.86
$2.06
$599
139.8%
118.2%
Coherus Oncology
$CHRS
1/21/25
Future Compounder
Active
Exited
2
$1,000
$1.37
$2.06
$1,504
50.4%
36.1%
Relay Therapeutics
$RLAY
1/10/25
Future Compounder
Active
Exited
0
$7,000
$4.32
$7.43
$12,045
72.1%
53.3%
AVITA Medical
$RCEL
1/8/25
Future Compounder
Active
Exited
9
$1,000
$9.53
$7.45
$782
-21.8%
-18.5%
Relay Therapeutics
$RLAY
12/10/24
Future Compounder
Active
Exited
0
$2,500
$4.44
$7.43
$4,179
67.2%
52.8%
Relay Therapeutics
$RLAY
12/3/24
Future Compounder
Active
Exited
0
$2,500
$4.45
$7.43
$4,179
67.2%
53.0%
Relay Therapeutics
$RLAY
11/20/24
Future Compounder
Active
Exited
0
$2,000
$4.55
$7.43
$3,267
63.3%
46.6%
Relay Therapeutics
$RLAY
10/29/24
Future Compounder
Active
Exited
0
$1,000
$5.80
$7.43
$1,282
28.2%
9.7%
Arrowhead Pharma
$ARWR
10/1/24
Future Compounder
Active
Exited
11
$1,000
$18.48
$63.64
$3,444
244.4%
224.2%
Relay Therapeutics
$RLAY
9/25/24
Future Compounder
Active
Exited
0
$725
$7.00
$7.43
$770
6.1%
-14.8%
Arrowhead Pharma
$ARWR
9/25/24
Future Compounder
Active
Exited
11
$1,000
$19.48
$63.64
$3,268
226.8%
206.9%
Relay Therapeutics
$RLAY
9/13/24
Future Compounder
Active
Exited
0
$1,000
$7.55
$7.43
$984
-1.6%
-24.2%
Relay Therapeutics
$RLAY
9/5/24
Future Compounder
Active
Exited
0
$2,000
$6.18
$7.43
$2,404
20.2%
-5.2%
Coherus Oncology
$CHRS
7/2/24
Future Compounder
Active
Exited
2
$1,000
$1.40
$2.06
$1,477
47.7%
22.1%
Exact Sciences
$EXAS
5/29/24
Current Compounder
Active
Exited
4
$1,000
$44.98
$102.26
$2,273
127.3%
102.4%
Relay Therapeutics
$RLAY
5/29/24
Future Compounder
Active
Exited
0
$1,000
$6.28
$7.43
$1,184
18.4%
-12.6%
Coherus Oncology
$CHRS
4/25/24
Future Compounder
Active
Exited
2
$6,996
$1.93
$2.06
$7,468
6.7%
-30.2%
Position
Ticker
Group
Status
Principal
Shares
Cost Basis
Last Price
Last Value
% Change
vs. SPY
Relay Therapeutics
$RLAY
Future Compounder
Building
Building
Building
0
$19,725
4,077.2
$6.28
$7.43
$30,294
53.6%
34.6%
Coherus Oncology
$CHRS
Future Compounder
Building
Building
Building
1
$9,246
5,362.8
$1.93
$2.06
$11,047
19.5%
-13.3%
Harmony Biosciences
$HRMY
Current Compounder
Full
Full
Full
2
$23,245
774.8
$30.00
$36.82
$28,529
22.7%
1.5%
Exact Sciences
$EXAS
Current Compounder
Full
Full
Full
2.5
$1,000
22.2
$44.98
$102.26
$2,273
127.3%
96.3%
Exact Sciences
$EXAS
Opportunistic
Exited
Exited
Exited
3
$10,000
223.8
$44.69
$53.05
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
Opportunistic
Exited
Exited
Exited
3
$10,000
113.4
$88.21
$98.73
$11,193
11.9%
8.9%
AVITA Medical
$RCEL
Future Compounder
Exited
Exited
Exited
3
$1,000
104.9
$9.53
$7.45
$782
-21.8%
-18.3%
Arrowhead Pharma
$ARWR
Future Compounder
Exited
Exited
Exited
3
$2,000
105.5
$18.96
$63.64
$6,712
235.6%
206.9%
Principal
$53,153
Current Value
$79,698
Total Return
49.9%
Benchmark
Ticker
Principal
Current Value
$ Change
% Change
Finch Trades vs.
Finch Trades
$FINCH
$53,153
$79,698
$26,545
49.9%
0.0%
If S&P 500
$SPY
$53,153
$65,725
$12,572
23.7%
26.2%
If XBI
$XBI
$53,153
$76,735
$23,582
44.4%
5.5%
If Nasdaq 100
$QQQ
$53,153
$68,763
$15,610
29.4%
20.5%
If ARKG
$ARKG
$53,153
$72,519
$19,366
36.4%
13.5%
Group
Principal
Last Value
% Change
vs. SPY
vs. QQQ
vs. XBI
vs. ARKG
Future Compounder
$31,971
$48,835
52.7%
30.4%
24.0%
16.1%
23.7%
Current Compounder
$24,245
$30,802
27.0%
5.4%
-0.7%
-26.0%
-16.4%
Opportunistic
$20,000
$23,064
15.3%
11.9%
13.3%
15.3%
14.9%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
Year
Principal
Last Value
% Change
vs. SPY
vs. QQQ
vs. XBI
vs. ARKG
2024
$23,721
$36,239
52.8%
27.3%
19.8%
15.6%
22.3%
2025
$52,495
$66,523
26.7%
13.2%
10.4%
-3.4%
2.4%
2026
$0
$0
0.0%
0.0%
0.0%
0.0%
0.0%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.
Research Notes
MOS Dashboard